Beranda › Kanker (semua jenis) › Ohio › Columbus
Uji klinis Kanker (semua jenis) di Columbus, OH
38 studi untuk Kanker (semua jenis) mencari peserta di lokasi sekitar Columbus (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
Menerima pesertaFase 1/2
- GSK Investigational Site, Columbus
Met Non Small Cell Cancer Registry (MOMENT)
Menerima pesertaStudi observasional
- The Ohio State University Wexner Medical Center, Columbus
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Menerima pesertaStudi observasional
- Ohio State University, Columbus
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Menerima pesertaFase 3
- The Ohio State University, Columbus
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Menerima pesertaStudi observasional
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
Menerima pesertaFase 2
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0008), Columbus
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Menerima pesertaFase 3
- Quetzal Site 8, Columbus
Pan Tumor Rollover Study
Menerima pesertaFase 2
- The Ohio University, Columbus
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Menerima pesertaFase 2/3
- Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Collection of Tissue Samples for Cancer Research
Menerima pesertaStudi observasional
- Ohio State University, Columbus
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Menerima pesertaFase 2
- The Ohio State University, Department of Psychiatry, Columbus
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Menerima pesertaFase 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Menerima pesertaStudi observasional
- Ohio State University, Columbus
Project: Every Child for Younger Patients With Cancer
Menerima pesertaStudi observasional
- Nationwide Children's Hospital, Columbus
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Menerima pesertaFase 2
- Nationwide Children's Hosp, Columbus
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Menerima pesertaFase 3
- Ohio State University Comprehensive Cancer Center, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- Riverside Methodist Hospital, Columbus
- dan 8 lainnya
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
Menerima pesertaFase 2
- Nationwide Children's Hospital, Columbus
The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients
Menerima peserta
- Nationwide Children's Hospital, Columbus
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Menerima pesertaFase 1/2
- The Ohio State University /ID# 271336, Columbus
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Menerima pesertaFase 1
- The Ohio State University Comprehensive Cancer Center, Columbus
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- Stefanie Spielman Comprehensive Breast Center, Columbus
Childhood Cancer Survivor Study
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Nationwide Children's Hospital, Columbus
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
Menerima pesertaStudi observasional
- Ohio State University, Columbus
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Menerima pesertaFase 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
Menerima pesertaFase 2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Menerima pesertaFase 1/2
- The Ohio State University Wexner Medical Center, Columbus
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Menerima pesertaFase 1/2
- Ohio State University Wexner Medical Center Gynecologic Oncology at Mill Run, Columbus
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Menerima pesertaFase 2
- The Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus
Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
Menerima pesertaStudi observasional
- Ohio State University Wexner Medical Center, Columbus
Re-Engaging AYA Survivors in Cancer-Related Healthcare
Menerima peserta
- Nationwide Children's Hospital, Columbus
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Menerima pesertaFase 2
- The Ohio State University /ID# 230439, Columbus
GEMINI-NSCLC: NSCLC Biomarker Study
Menerima pesertaStudi observasional
- Ohio State University, Columbus
- OhioHealth Reseach Institute, Columbus
Preparing for Life and Academics for Young Childhood Cancer Survivors
Menerima peserta
- Nationwide Children's Hospital, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Columbus
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Menerima pesertaFase 1/2
- The Ohio State University, Columbus
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Menerima pesertaStudi observasional
- Ohio State University, Columbus
- OhioHealth Research Institute, Columbus
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Menerima peserta
- Ohio State University Comprehensive Cancer Center, Columbus
Uji klinis Kanker (semua jenis) di kota lain
- Houston, TX121 studi
- New York City, NY110 studi
- Boston, MA86 studi
- Los Angeles, CA73 studi
- Nashville, TN65 studi
- Philadelphia, PA59 studi
- Durham, NC58 studi
- Washington, DC58 studi
- Chicago, IL51 studi
- Seattle, WA49 studi
- Atlanta, GA49 studi
- Arlington, VA48 studi
Studi lain di Columbus
- Kanker Paru Non-Sel Kecil56 studi
- Kanker Payudara39 studi
- Kanker Ovarium39 studi
- Kanker Paru37 studi
- Leukemia Mieloid Akut35 studi
- Leukemia Limfositik Kronis28 studi
- Kanker Metastatik27 studi
- Kanker Endometrium25 studi
- Kanker Kolorektal24 studi
- Kanker Prostat24 studi
- Mieloma Multipel24 studi
- Melanoma21 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.